Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smartphone app boosts chemo nurse Know-How in small trial

NCT ID NCT06976450

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a mobile app called ChemoNurs, designed to help oncology nurses learn about chemotherapy drugs. Fifty-nine nurses from one hospital in Turkey used the app, and researchers measured changes in their knowledge and attitudes. The goal was to see if a simple smartphone tool could improve how nurses handle chemotherapy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ChemoNurs mobile application
What this could lead to
If effective, this app could become a simple tool to help nurses feel more confident and knowledgeable when giving chemotherapy.
What could go wrong
This was a small, single-center study with only 59 nurses. Results may not apply to other hospitals or countries, and the app's long-term impact is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

59 people

The number who actually took part.

Started

Aug 2023

Finished

May 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Actively administering chemotherapy treatments * Having knowledge of how to use an Android or iOS smartphone * Possessing mobile literacy * Working in oncology clinics for a duration of 0-12 months * Volunteering to participate in the study Exclusion Criteria: * Not having completed the orientation process in oncology clinics * Not having administered chemotherapy * Incomplete responses in the data collection forms * Willingness to withdraw at any stage of the study * Participation in the Oncology Nursing Certification Program * Prior attendance in courses or training sessions related to chemotherapy drugs

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chemotherapy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hacettepe University Oncology Hospital

    Ankara, Altındağ, 06230, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.